CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Dose Escalation Trial of Alpha-Tocopheryloxyacetic Acid (α-TEA) in Patients With Treatment Refractory HER2+ Metastatic Breast Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04120246
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:23.038173+00:00
Published At: 2024-07-10T00:00:00+00:00
Record Updated At: 2024-07-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Anatomic Stage IV Breast Cancer AJCC v8", "HER2 Positive Breast Carcinoma", "Metastatic Breast Carcinoma", "Refractory Breast Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-07-10"
protocolSection.identificationModule.nctId: "NCT04120246"
protocolSection.identificationModule.officialTitle: "A Phase I Dose Escalation Trial of Alpha-Tocopheryloxyacetic Acid (\u03b1-TEA) in Patients With Treatment Refractory HER2+ Metastatic Breast Cancer"
protocolSection.statusModule.overallStatus: "SUSPENDED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.